The galanin receptor 1 gene associates with tobacco craving in smokers seeking cessation treatment

Neuropsychopharmacology

Volumn 36, Issue 7, 2011, Pages 1412-1420

  Lori, Adriana ^a   Tang, Yilang ^a   O'Malley, Stephanie ^b   Picciotto, Marina R ^b   Wu, Ran ^b   Conneely, Karen N ^a   Cubells, Joseph F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

craving; Fagerstr m Test for Nicotine Dependence; GALR1; Minnesota Withdrawal Scale; nicotine dependence; smoking

Indexed keywords

CHRNA5 PROTEIN; GALANIN RECEPTOR 1; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EUROPEAN AMERICAN; FEMALE; GENE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; PHENOTYPE; PRIORITY JOURNAL; RATING SCALE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING CESSATION PROGRAM; TOBACCO; TOBACCO DEPENDENCE;

ADULT; COMPUTATIONAL BIOLOGY; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; QUESTIONNAIRES; RECEPTOR, GALANIN, TYPE 1; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 79956021645     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.25     Document Type: Article

References (77)

1. Aubin HJ, Peiffer G, Stoebner-Delbarre A, Vicaut E, Jeanpetit Y, Solesse A et al (2010). The French Observational Cohort of Usual Smokers (FOCUS) cohort: French smokers perceptions and attitudes towards smoking cessation. BMC Public Health 10: 100.
2. Baker TB, Weiss RB, Bolt D, von Niederhausern A, Fiore MC, Dunn DM et al (2009). Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res 11: 785-796.
3. Belfer I, Hipp H, Bollettino A, McKnight C, Evans C, Virkkunen M et al (2007). Alcoholism is associated with GALR3 but not two other galanin receptor genes. Genes Brain Behav 6: 473-481. (Pubitemid 47024960)
4. Berrettini W, Yuan X, Tozzi F, Song K, Francks C, Chilcoat H et al (2008). Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13: 368-373. (Pubitemid 351399826)
5. Bierut LJ (2009). Nicotine dependence and genetic variation in the nicotinic receptors. Drug Alcohol Depend 104(Suppl 1): S64-S69.
6. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF et al (2007). Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 16: 24-35. (Pubitemid 46152542)
7. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X et al (2008). Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165: 1163-1171.
8. Conti DV, Lee W, Li D, Liu J, Van Den Berg D, Thomas PD et al (2008). Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet 17: 2834-2848.
9. Drgon T, Montoya I, Johnson C, Liu QR, Walther D, Hamer D et al (2009). Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. Mol Med 15: 21-27.
10. Ehrich M, Bocker S, van den Boom D (2005). Multiplexed discovery of sequence polymorphisms using base-specific cleavage and MALDI-TOF MS. Nucleic Acids Res 33: e38.
11. Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH (2004). Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. Pharmaco-genomics J 4: 102-109. (Pubitemid 38499993)
12. Falush D, Stephens M, Pritchard JK (2007). Inference of population structure using multilocus genotype data: dominant markers and null alleles. Mol Ecol Notes 7: 574-578. (Pubitemid 47035522)
13. Fejerman L, John EM, Huntsman S, Beckman K, Choudhry S, Perez-Stable et al (2008). Genetic ancestry and risk of breast cancer among US Latinas. Cancer Res 68: 9723-9728.
14. Franklin TR, Wang Z, Wang J, Sciortino N, Harper D, Li Y et al (2007). Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsycho-pharmacology 32: 2301-2309. (Pubitemid 47587682)
15. Fulton S, Pissios P, Manchon RP, Stiles L, Frank L, Pothos EN et al (2006). Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51: 811-822. (Pubitemid 44374918)
16. Gabriel S, Ziaugra L, Tabbaa D (2009). SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet Chapter Chapter 2: Unit 2 12.
17. Gauderman WJ (2002a). Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155: 478-484. (Pubitemid 34174160)
18. Gauderman WJ (2002b). Sample size requirements for matched case-control studies of gene-environment interaction. Statist Med 21: 35-50. (Pubitemid 34065703)
19. Gmitrowicz A, Kucharska A (1994). Developmental disorders in the fourth edition of the American classification: diagnostic and statistical manual of mental disorders (DSM IVFoptional book). Psychiatr Pol 28: 509-521. (Pubitemid 24344314)
20. Greenbaum L, Lerer B (2009). Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions. Mol Psychiatry 14: 912-945.
21. Haberstick BC, Timberlake D, Ehringer MA, Lessem JM, Hopfer CJ, Smolen A et al (2007). Genes, time to first cigarette and nicotine dependence in a general population sample of young adults. Addiction 102: 655-665. (Pubitemid 46398839)
22. Hariharan M, VanNoord T, Greden JF (1988). A high performance liquid chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. Clin Chem 34: 724-729.
23. Hatsukami D, Lexau B, Nelson D, Pentel PR, Sofuoglu M, Goldman A (1998). Effects of cotinine on cigarette self-administration. Psychopharmacology (Berl) 138: 184-189. (Pubitemid 28330836)
24. Hawes JJ, Brunzell DH, Narasimhaiah R, Langel U, Wynick D, Picciotto MR (2008). Galanin protects against behavioral and neurochemical correlates of opiate reward. Neuropsychopharma-cology 33: 1864-1873. (Pubitemid 351832595)
25. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991). The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86: 1119-1127.
26. Holmes A, Kinney JW, Wrenn CC, Li Q, Yang RJ, Ma L et al (2003). Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology 28: 1031-1044.
27. Hughes J, Hatsukami DK (1998). Errors in using tobacco withdrawal scale. Tob Control 7: 92-93.
28. Hughes JR, Bickel WK, Higgins ST (1992). Alcohol and addictions. Am J Psychiatry 149: 1118; author reply 1118-1119.
29. Hughes JR, Hatsukami D (1986). Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43: 289-294. (Pubitemid 16052281)
30. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D et al (2008). A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633-637. (Pubitemid 351483367)
31. Keskitalo K, Tuorila H, Spector TD, Cherkas LF, Knaapila A, Silventoinen K et al (2007). Same genetic components underlie different measures of sweet taste preference. Am J Clin Nutr 86: 1663-1669. (Pubitemid 350232181)
32. Killen JD, Fortmann SP (1997). Craving is associated with smoking relapse: findings from three prospective studies. Exp Clin Psychopharmacol 5: 137-142. (Pubitemid 27239815)
33. Killen JD, Fortmann SP, Murphy Jr GM, Hayward C, Arredondo C, Cromp D et al (2006). Extended treatment with bupropion SR for cigarette smoking cessation. J Consult Clin Psychol 74: 286-294. (Pubitemid 43807361)
34. Kim WJ, Hersh CP, DeMeo DL, Reilly JJ, Silverman EK (2009). Genetic association analysis of COPD candidate genes with bronchodilator responsiveness. Respir Med 103: 552-557.
35. Koob GF, Volkow ND (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
36. Levran O, Londono D, O'Hara K, Nielsen DA, Peles E, Rotrosen J et al (2008). Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav 7: 720-729.
37. Li MD (2008). Identifying susceptibility loci for nicotine dependence: 2008 update based on recent genome-wide linkage analyses. Hum Genet 123: 119-131.
38. Li MD, Cheng R, Ma JZ, Swan GE (2003). A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98: 23-31. (Pubitemid 36044333)
39. Li MD, Xu Q, Lou XY, Payne TJ, Niu T, Ma JZ (2009). Association and interaction analysis of variants in CHRNA5/CHRNA3/ CHRNB4 gene cluster with nicotine dependence in African and European Americans. Am J Med Genet Part B 5: 745-756.
40. Li MD, Yoon D, Lee JY, Han BG, Niu T, Payne TJ et al (2010). Associations of variants in CHRNA5/A3/B4 gene cluster with smoking behaviors in a Korean population. PLoS One 16: e12183.
41. Maes HH, Sullivan PF, Bulik CM, Neale MC, Prescott CA, Eaves LJ et al (2004). A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol Med 34: 1251-1261. (Pubitemid 39517155)
42. Melnikova VI, Raison D, Hardin-Pouzet H, Ugrumov MV, Calas A, Grange-Messent V (2006). Noradrenergic regulation of galanin expression in the supraoptic nucleus in the rat hypothalamus. An ex vivo study. J Neurosci Res 83: 857-863.
43. Narasimhaiah R, Kamens HM, Picciotto MR (2009). Effects of galanin on cocaine-mediated conditioned place preference and ERK signaling in mice. Psychopharmacology (Berl) 204: 95-102.
44. Novak G, Boukhadra J, Shaikh SA, Kennedy JL, Le Foll B (2009). Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: a preliminary study. World J Biol Psychiatry 10(Part 3): 929-935.
45. Nussbaum J, Xu Q, Payne TJ, Ma JZ, Huang W, Gelernter J et al (2008). Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers. Hum Mol Genet 17: 1569-1577. (Pubitemid 351737161)
46. O'Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL et al (2006). A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Arch Intern Med 166: 667-674.
47. Pergadia ML, Agrawal A, Loukola A, Montgomery GW, Broms U, Saccone SF et al (2009). Genetic linkage findings for DSM-IV nicotine withdrawal in two populations. Am J Med Genet B 150B: 950-959.
48. Pergadia ML, Heath AC, Martin NG, Madden PA (2006). Genetic analyses of DSM-IV nicotine withdrawal in adult twins. Psychol Med 36: 963-972. (Pubitemid 43827368)
49. Perkins KA, Lerman C, Mercincavage M, Fonte CA, Briski JL (2009). Nicotinic acetylcholine receptor beta2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patch. Cancer Epidemiol Biomarkers Prev 18: 2608-2612.
50. Piasecki TM (2006). Relapse to smoking. Clin Psychol Rev 26: 196-215. (Pubitemid 43238388)
51. Picciotto MR, Brabant C, Einstein EB, Kamens HM, Neugebauer NM (2010). Effects of galanin on monoaminergic systems and HPA axis: potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors. Brain Res 1314: 206-218.
52. Pritchard JK, Stephens M, Donnelly P (2000a). Inference of population structure using multilocus genotype data. Genetics 155: 945-959. (Pubitemid 30397141)
53. Pritchard JK, Stephens M, Rosenberg NA, Donnelly P (2000b). Association mapping in structured populations. Am J Hum Genet 67: 170-181. (Pubitemid 30481554)
54. Radloff LS (1977). The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measure 1: 385-401.
55. Robinson JK, Brewer A (2008). Galanin: a potential role in mesolimbic dopamine-mediated instrumental behavior. Neurosci Biobehav Rev 32: 1485-1493.
56. Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E et al (2002). The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 70: 758-762. (Pubitemid 34177929)
57. Saccone NL, Wang JC, Breslau N, Johnson EO, Hatsukami D, Saccone SF et al (2009). The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res 69: 6848-6856.
58. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA et al (2007). Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16: 36-49. (Pubitemid 46152543)
59. Stern MC, Conti DV, Siegmund KD, Corral R, Yuan JM, Koh WP et al (2007). DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 16: 2363-2372. (Pubitemid 351196369)
60. Stevens VL, Bierut LJ, Talbot JT, Wang JC, Sun J, Hinrichs AL et al (2008). Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiol Biomarkers Prev 17: 3517-3525.
61. Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A (2005). Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72h. Psychopharmacology (Berl) 183: 1-12. (Pubitemid 41484177)
62. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP et al (2008). A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642. (Pubitemid 351483366)
63. Tiffany ST, Warthen MW, Goedeker KC (2009). The functional significance of craving in nicotine dependence. Nebr Symp Motiv 55: 171-197.
64. Toll BA, O'Malley SS, Katulak NA, Wit R, Dubin JA, Latimer A et al (2007a). Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial. Psychol Addict Behav 21: 534-544.
65. Tobacco and Genetics Consortiium (2010). Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 42: 441-447.
66. Toll BA, O'Malley SS, McKee SA, Salovey P, Krishnan-Sarin S (2007b). Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale. Psychol Addict Behav 21: 216-225. (Pubitemid 47445181)
67. Toll BA, White M, Wu R, Meandzija B, Jatlow P, Makuch R et al (2010). Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial. Drug Alcohol Depend 111: 200-206.
68. True WR, Heath AC, Scherrer JF, Waterman B, Goldberg J, Lin N et al (1997). Genetic and environmental contributions to smoking. Addiction 92: 1277-1287. (Pubitemid 27470118)
69. Uhl GR, Drgon T, Johnson C, Ramoni MF, Behm FM, Rose JE (2010). Genome wide association for smoking cessation success in a trial of precessation nicotine replacement. Mol Med 2010: 00052.
70. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE et al (2008). Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry 65: 683-693. (Pubitemid 351787239)
71. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE (2007). Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs. BMC Genet 8: 10.
72. Weiss RB, Baker TB, Cannon DS, von Niederhausern A, Dunn DM, Matsunami N et al (2008). A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 4: e1000125.
73. World Health Organization (2008). The World Health Statistic: Reducing Deaths from Tobacco. World Health Organization (WHO): Geneva, Switzerland.
74. Xian H, Scherrer JF, Madden PA, Lyons MJ, Tsuang M, True WR et al (2003). The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. Nicotine Tob Res 5: 245-254. (Pubitemid 36547008)
75. Zachariou V, Georgescu D, Kansal L, Merriam P, Picciotto MR (2001). Galanin receptor 1 gene expression is regulated by cyclic AMP through a CREB-dependent mechanism. J Neurochem 76: 191-200. (Pubitemid 32044382)
76. Zachariou V, Parikh K, Picciotto MR (1999). Centrally administered galanin blocks morphine place preference in the mouse. Brain Res 831: 33-42. (Pubitemid 29336185)
77. Zachariou V, Thome J, Parikh K, Picciotto MR (2000). Upregula-tion of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal. Neuropsychopharmaco-logy 23: 127-137. (Pubitemid 30406897)